Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Thalidomide/adverse effects"'
Autor:
Mary E. Guckert, A. Kate Sasser, Pamela L. Clemens, Antonio Palumbo, Steen Lisby, Tahamtan Ahmadi, Paul G. Richardson, Linda Basse, Henk M. Lokhorst, Jakub Krejcik, Charlotte Lemech, Jacob P. Laubach, Howard Yeh, Jianping Wang, Torben Plesner, Ulrik Lassen, Monique C. Minnema, Carla de Boer, Hendrik-Tobias Arkenau, Peter Gimsing, Nushmia Z. Khokhar
Publikováno v:
Blood, 128(14), 1821-1828. American Society of Hematology
Blood, 128(14), 1821. American Society of Hematology
Plesner, T, Arkenau, H-T, Gimsing, P, Krejcik, J, Lemech, C, Minnema, M C, Lassen, U, Laubach, J P, Palumbo, A, Lisby, S, Basse, L, Wang, J, Sasser, A K, Guckert, M E, de Boer, C, Khokhar, N Z, Yeh, H, Clemens, P L, Ahmadi, T, Lokhorst, H M & Richardson, P G 2016, ' Phase 1/2 study of daratumumab, lenalidomide, and dexamethasone for relapsed multiple myeloma ', Blood, vol. 128, no. 14, pp. 1821-1828 . https://doi.org/10.1182/blood-2016-07-726729
Blood, 128(14), 1821. American Society of Hematology
Plesner, T, Arkenau, H-T, Gimsing, P, Krejcik, J, Lemech, C, Minnema, M C, Lassen, U, Laubach, J P, Palumbo, A, Lisby, S, Basse, L, Wang, J, Sasser, A K, Guckert, M E, de Boer, C, Khokhar, N Z, Yeh, H, Clemens, P L, Ahmadi, T, Lokhorst, H M & Richardson, P G 2016, ' Phase 1/2 study of daratumumab, lenalidomide, and dexamethasone for relapsed multiple myeloma ', Blood, vol. 128, no. 14, pp. 1821-1828 . https://doi.org/10.1182/blood-2016-07-726729
Daratumumab, a human CD38 immunoglobulin G1 kappa (IgG1κ) monoclonal antibody, has activity as monotherapy in multiple myeloma (MM). This phase 1/2 study investigated daratumumab plus lenalidomide/dexamethasone in refractory and relapsed/refractory
Autor:
Elisabetta Buscarini, Luisa Maria Botella, Urban Geisthoff, Anette D. Kjeldsen, Hans Jurgen Mager, Fabio Pagella, Patrizia Suppressa, Roberto Zarrabeitia, Sophie Dupuis-Girod, Claire L. Shovlin, on behalf of VASCERN-HHT
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
Orphanet Journal of Rare Diseases, Vol 14, Iss 1, Pp 1-14 (2019)
Buscarini, E, Botella, L M, Geisthoff, U, Kjeldsen, A D, Mager, H J, Pagella, F, Suppressa, P, Zarrabeitia, R, Dupuis-Girod, S, Shovlin, C L & on behalf of VASCERN-HHT 2019, ' Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia ', Orphanet Journal of Rare Diseases, vol. 14, 28 . https://doi.org/10.1186/s13023-018-0982-4
Orphanet Journal of Rare Diseases
instname
Orphanet Journal of Rare Diseases, Vol 14, Iss 1, Pp 1-14 (2019)
Buscarini, E, Botella, L M, Geisthoff, U, Kjeldsen, A D, Mager, H J, Pagella, F, Suppressa, P, Zarrabeitia, R, Dupuis-Girod, S, Shovlin, C L & on behalf of VASCERN-HHT 2019, ' Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia ', Orphanet Journal of Rare Diseases, vol. 14, 28 . https://doi.org/10.1186/s13023-018-0982-4
Orphanet Journal of Rare Diseases
[Background] Hereditary hemorrhagic telangiectasia (HHT) is a multisystemic inherited vascular dysplasia that leads to nosebleeds and visceral arteriovenous malformations (AVMs). Anti-angiogenic drugs thalidomide and bevacizumab have been increasingl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c420f321730820d8a6f67fa5fe41daf5
http://hdl.handle.net/10044/1/67482
http://hdl.handle.net/10044/1/67482
Autor:
Stavros Kiliaridis, Lotta Sjögreen
Publikováno v:
Journal of Laryngology and Otology, Vol. 126, No 9 (2012) pp. 902-6
Background:Earlier studies have shown that individuals with thalidomide embryopathy can have skeletal deformities, ear and eye aberrations, and facial palsy. This study aimed to survey the frequency and characteristics of facial palsy in this group o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4e09408e722b9e05c66e245ac06a664
http://doc.rero.ch/record/292554/files/S0022215112001429.pdf
http://doc.rero.ch/record/292554/files/S0022215112001429.pdf
Autor:
C.J.J. Westermann, Repke J. Snijder, Christine L. Mummery, Frans Disch, Johannes J. Mager, Anna E Hosman
Publikováno v:
Rhinology, 53(4), 340-344
Background: Patients with a hereditary vascular disorder called Rendu-Osler-Weber syndrome (Hereditary Haemorrhagic Telangiectasia, HHT) haemorrhage easily due to weak-walled vessels. Haemorrhage in lungs or brain can be fatal but patients suffer mos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::423062000a15442995b26c6ad565d1d9
https://hdl.handle.net/1887/105570
https://hdl.handle.net/1887/105570
Autor:
Taverna, C., Bargetzi, M., Betticher, D., Gmur, J., Gregor, M., Heim, D., Hess, U., Ketterer, N., Lerch, E., Matthes, Thomas, Mey, U., Pabst, T., Renner, Christoph
Publikováno v:
Swiss Medical Weekly, vol. 140, pp. w13054
Schweizerische medizinische Wochenschrift, Vol. 140 (2010) P. w13054
Schweizerische medizinische Wochenschrift, Vol. 140 (2010) P. w13054
The treatment of multiple myeloma has undergone significant changes in the recent past. The arrival of novel agents, especially thalidomide, bortezomib and lenalidomide, has expanded treatment options and patient outcomes are improving significantly.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::f630e5a07ef469b041755bd84db8ab07
https://serval.unil.ch/resource/serval:BIB_8873EB254E5F.P001/REF.pdf
https://serval.unil.ch/resource/serval:BIB_8873EB254E5F.P001/REF.pdf
Autor:
Thorsten Braun, Grégory Jouvion, Olivier Lortholary, Jean-Michel Correas, Sophie Candon, C. Maunoury, Blandine Rammaert, Marie-Elisabeth Bougnoux
Publikováno v:
Transplant Infectious Disease
Transplant Infectious Disease, Wiley, 2017, 19 (1), pp.e12637. ⟨10.1111/tid.12637⟩
Transplant Infectious Disease, 2017, 19 (1), pp.e12637. ⟨10.1111/tid.12637⟩
Transplant Infectious Disease, Wiley, 2017, 19 (1), pp.e12637. ⟨10.1111/tid.12637⟩
Transplant Infectious Disease, 2017, 19 (1), pp.e12637. ⟨10.1111/tid.12637⟩
International audience; Chronic disseminated candidiasis (CDC) is a rare and difficult‐to‐treat invasive fungal disease occurring mainly after prolonged and profound neutropenia. We describe the case of a 59‐year‐old man successfully treated
Autor:
Konstantinos L. Bourantas, Aristeidis Chaidos, H.D. Kapsali, Stavroula Tsiara, Evagelia Tzouvara
Publikováno v:
Acta Haematologica. 109:153-155
Acta Haematol
Autor:
Jorge Cardoso, Ana Afonso, Heinz Kutzner, Candida Fernandes, João Machado, Sandra Medeiros, Nídia Martins, Fernando Maltez, Raquel Vieira
Publikováno v:
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
Auteur(s) : Sandra Medeiros1, Candida Fernandes1, Nidia Martins2, Joao Machado2, Heinz Kutzner3, Ana Afonso4, Raquel Vieira1, Fernando Maltez5, Jorge Cardoso1 1Dermatology Department, Curry Cabral Hospital, Rua da Beneficiencia n°8, 1069-166 Lisbon,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cd122fcc334577171362468a7ddc257
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.